12.06.18

Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenses

Source: Bausch + Lomb

12.04.18

Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic Laser

Source: Bausch + Lomb

10.24.18

Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite on IBM Cloud

Source: Bausch + Lomb

09.05.18

Phase 3 Trial of Bausch + Lomb’s Loteprednol Etabonate Drug Candidate Meets Primary Efficacy Endpoints

Source: Bausch Health Companies

08.27.18

Bausch + Lomb Launches Expanded Parameters of Biotrue ONEday for Astigmatism Contact Lenses

Source: Bausch + Lomb

08.24.18

Contact Lens Companies Seek Summary Judgment in Lawsuit Over Minimum Pricing

Source: Vision Monday

08.22.18

Joseph Gordon Named US President of Bausch + Lomb

Source: Bausch + Lomb

07.19.18

Bausch + Lomb Retina News, Events

Source: Bausch + Lomb

07.09.18

Bausch + Lomb Announces FDA Filing Acceptance for Loteprednol Etabonate Ophthalmic Gel

Source: Bausch + Lomb

06.27.18

Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Hydra-Peg Custom Contact Lens Coating

Source: Bausch + Lomb

View more stories